Randomized Phase 3 Study of Panitumumab With FOLFOX4 Compared to FOLFOX4 Alone as 1(st)-line Treatment (tx) for Metastatic Colorectal Cancer (mCRC): The PRIME Trial
帕尼单抗联合 FOLFOX4 方案与 FOLFOX4 单药方案作为转移性结直肠癌 (mCRC) 一线治疗的随机 3 期研究：PRIME 试验
期刊:BMC Public Health
影响因子:3.6
doi:10.1186/s12889-021-10459-8
Ibe, Chidinma A; Haywood, Danielle R; Creighton, Ciana; Cao, Yidan; Gabriel, Angel; Zare, Hossein; Jones, Wehmah; Yang, Manshu; Balamani, Michele; Gaston, Marilyn; Porter, Gayle; Woods, Denise L; Gaskin, Darrell J; Douillard, JY; Siena, S; Cassidy, J; Tabernero, J; Burkes, R; Barugel, ME; Humblet, Y; Cunningham, D; Wolf, M; Gansert, J
